The relationship between human microbiome and disease has been scientifically proven due to the revolutionary development of DNA sequencing analysis technology. In particular, the gut microbiome of healthy people has been shown to be practical in treating and preventing various diseases, and accordingly, human microbiome is expected to develop into a national strategic industry.

HealthBiome Inc. based on the separation technology of unculturable strict anaerobic gut mictrobiota has identified candidate strains with great efficacy of treating incurable diseases, and has secured its own microbes effective in improving immuno-oncology therapies, CNS disorders as well as metabolic syndromes. Moreover, HealthBiome is exploring potential drug substances and developing them as biopharmaceuticals that meet global standards using advanced biotechnologies such as optimization of mass production of strict anaerobic microbiome, multi-omics analysis, and animal disease model tests.